Adems, algunas investigaciones sugieren que el uso de GLP-1s inhibe las seales de sed por lo que es an ms importante mantenerse hidratado
Alibilli, A.S., Jain, V., Mane, H., Yue, X., Ratzki-Leewing, A., Merchant, J.S., Criss, S., Nguyen, Q.C., McCoy, R.G., Nguyen, T.T
At Esthetic Solutions, our approach goes beyond surface-level beauty treatments
Risk factors that may prompt additional consideration include: Active gastrointestinal symptoms (nausea, vomiting, abdominal pain) Recent dose increases or being in the dose-escalation phase Higher doses of semaglutide Known gastroparesis or other conditions affecting gastric emptying Obesity with GERD or hiatal hernia Based on the 2024 multi-society guidance, most patients can continue GLP-1 receptor agonists before elective procedures with appropriate risk assessment and mitigation strategies, rather than automatic postponement
You want whatever schedule you are least likely to forget